Dirk Groenewegen
Profile
Dirk Groenewegen is the founder of Glycostem Therapeutics BV, which was founded in 2007.
He held the title of Director-Supervisory Board.
Dr. Groenewegen has a doctorate from the University of Hamburg and a graduate degree from Delft University of Technology.
Former positions of Dirk Groenewegen
| Companies | Position | End |
|---|---|---|
Glycostem Therapeutics BV
 Glycostem Therapeutics BV BiotechnologyHealth Technology Glycostem Therapeutics BV operates as a life science company which develops cellular immunotherapy and production technology platforms. It develops cellular immunotherapeutic for the treatment of leukemia, lymphomas, and other forms of cancer. The firm provides Prototype NK-cell and NK-cell progenitor cell products for clinical evaluations and intervention studies; and GBGM, a cell survival and minimal cellular delineation in expansion and differentiation experiments. The company was founded by Dirk Groenewegen and Jan van der Hoeven in 2007 and is headquartered in Oss, the Netherlands. | Founder | - |
Training of Dirk Groenewegen
| University of Hamburg | Doctorate Degree |
| Delft University of Technology | Graduate Degree |
Experiences
Positions held
Linked companies
| Private companies | 1 |
|---|---|
Glycostem Therapeutics BV
Glycostem Therapeutics BV BiotechnologyHealth Technology Glycostem Therapeutics BV operates as a life science company which develops cellular immunotherapy and production technology platforms. It develops cellular immunotherapeutic for the treatment of leukemia, lymphomas, and other forms of cancer. The firm provides Prototype NK-cell and NK-cell progenitor cell products for clinical evaluations and intervention studies; and GBGM, a cell survival and minimal cellular delineation in expansion and differentiation experiments. The company was founded by Dirk Groenewegen and Jan van der Hoeven in 2007 and is headquartered in Oss, the Netherlands. | Health Technology |
- Stock Market
- Insiders
- Dirk Groenewegen
